T cells or NK cells in the peripheral blood showed a pattern similar to that of tumor samples, indicating that Q702 treatment increased the proportion of IFN-γ-producing CD4 T and NK cells and granzyme B+ CD8 T cells (Figure 5B). This evidence concerns the gene CD4 and neoplasm.